Clinical Trial Update: Isradipine Enhancement of Virtual Reality Cue Exposure for Smoking Cessation [EARLY_Phase 1]

View source ↗

Summary

Early Phase 1 trial evaluating whether isradipine enhances virtual reality cue-exposure therapy for smoking cessation; results have been posted after completion…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Tobacco Use Disorder

Drugs mentioned

• Isradipine (isradipine)

Snippet

Sponsor: University of Texas at Austin | Conditions: Nicotine Dependence, Smoking, Cigarette | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2025-06-15